Pancreatic cancer tumors show differences between racial groups in study
Summarised from 2 outlets · Updated 17 Nov, 17:08 · Archive
A University of Cincinnati study of 22 pancreatic tumors found distinct cellular differences in Black patients that could inform personalised treatment approaches.
A University of Cincinnati study examined 22 pancreatic tumors from patients of different racial backgrounds, including seven Black patients and 15 non-African American patients, to identify differences in cancer cells and immune system responses. The findings were published in the journal Cancer Research.
Tumors from Black patients had fewer of the most common type of pancreatic cancer cells but more cells with mixed characteristics, some of which have been associated with drug resistance. The study did not, however, establish whether these cellular differences affected patients' treatment outcomes. Black patients' tumors also contained more B cells, a type of immune cell, and larger clusters of immune cells. Researchers found signs that some B cells may suppress the body's response to cancer, though the significance of these differences remains unclear.
Dr. Raymond Wadlow, a gastrointestinal medical oncologist at Inova Schar Cancer Institute in Virginia, noted that immunotherapy in pancreatic cancer is particularly challenging because 'the pancreatic tumor subverts the immune system so that it is fighting for it instead of for the host or the rest of the body'. The study found no significant differences between groups in the major genetic changes known to drive pancreatic cancer.

How it is being reported
- Pancreatic cancer mystery deepens as researchers make unexpected discoveryA UC study of 22 pancreatic tumors found distinct cell differences in Black patients, which could help researchers develop personalized treatments.New York Post · 17 Nov, 16:51
- Pancreatic cancer mystery deepens as researchers make unexpected discoveryUniversity of Cincinnati study found Black patients' pancreatic tumors had more B cells and cells tied to drug resistance, pointing to tailored care.Fox News · 17 Nov, 12:00
In this story: University of Cincinnati · Cancer Research · Inova Schar Cancer Institute · Virginia · Raymond Wadlow
This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log
Comments (0)